Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients

Since 2010, the European Medicines Agency (EMA) has provided access to clinical study reports (CSRs). We requested CSRs for randomized controlled trials (RCTs) of erythropoiesis-stimulating agents (ESAs) in cancer patients from EMA and identified RCT publications with literature searches. We assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohner, Eliane, Grabik, Michael, Tonia, Thomy, Jüni, Peter, Pétavy, Frank, Pignatti, Francesco, Bohlius, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724886/
https://www.ncbi.nlm.nih.gov/pubmed/29228059
http://dx.doi.org/10.1371/journal.pone.0189309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724886/
https://www.ncbi.nlm.nih.gov/pubmed/29228059
http://dx.doi.org/10.1371/journal.pone.0189309

Ejemplares similares